MP:0000189 | hypoglycemia | "low levels of plasma glucose in the circulating blood; this generally refers to a pathological state" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8] |
Show
Allelic Composition: Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd,Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd Genetic Background: involves: 129S6/SvEvTac * 129X1/SvJ
|
MP:0000313 | abnormal cell death | "anomalous cessation of function at the cellular level" [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Mapk7tm1Wnt/Mapk7tm1Wnt Genetic Background: involves: C57BL/6
|
MP:0000598 | abnormal liver morphology | "malformation or absence of this bile-secreting exocrine gland, which is important for detoxification; for fat, carbohydrate, and protein metabolism; and for glycogen storage " [Stedman s Medical Dictionary:ISBN 0-683-40008-8, MGI:CLS, J:23170] |
Show
Allelic Composition: Trip13Gt(CH0621)Wtsi/Trip13Gt(CH0621)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0000849 | abnormal cerebellum morphology | "any malformation or absence of the part of the metencephalon that lies in the posterior cranial fossa dorsal to the pons and medulla that is concerned with the coordination of movement and learning of motor skills" [J:50311, Principles of Neural Science , 3rd edition:ISBN 0-8385-8034-3] |
Show
Allelic Composition: Gab1tm2Wbm/Gab1tm2Wbm Genetic Background: involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1
|
MP:0000877 | abnormal Purkinje cell | "any structural anomaly of the neurons located at the interface of the molecular and internal granule layers of the cerebellar cortex; these inhibitory neurons provide the output of the cerebellar cortex through axons that project into the white matter, and extensive dendritic trees from the Purkinje cells extend upward in a single plane into the molecular layer where they synapse with parallel fibers of granule cells" [J:46140, Principles of Neural Science , 3rd edition:ISBN 0-8385-8034-3] |
Show
Allelic Composition: Gab1tm2Wbm/Gab1tm2Wbm Genetic Background: involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1
|
MP:0001262 | decreased body weight | "lower than normal average weight " [J:61295] |
Show
Allelic Composition: Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd,Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd Genetic Background: involves: 129S6/SvEvTac * 129X1/SvJ
|
MP:0001265 | reduced body size | "smaller than average body weight, height and/or length of an organism compared to controls" [Stedman s Medical Dictionary , 27th edition:ISBN 0-683-40008-8, J:23170] |
Show
Allelic Composition: Ghrtm1.2Masp/Ghrtm1.2Masp Genetic Background: involves: 129S4/SvJaeSor
|
MP:0001393 | ataxia | "inability to coordinate voluntary muscular movements" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:67231] |
Show
Allelic Composition: Gab1tm2Wbm/Gab1tm2Wbm Genetic Background: involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * CD-1
|
MP:0001732 | postnatal growth retardation | "slow or limited development after birth " [Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd,Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd Genetic Background: involves: 129S6/SvEvTac * 129X1/SvJ
|
MP:0002310 | resistance to fatty liver development | "less likely than the norm to to develop hepatic steatosis " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Trip13Gt(CH0621)Wtsi/Trip13Gt(CH0621)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0002888 | abnormal NMDA-mediated synaptic currents | "change in the measured amplitude or duration of response to stimulation of NMDA receptors" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Mapk7tm1Wnt/Mapk7tm1Wnt Genetic Background: involves: C57BL/6
Allelic Composition: Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd,Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd Genetic Background: involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6
|
MP:0002891 | increased insulin sensitivity | "greater ability to clear glucose from the bloodstream when given insulin than normal; can result in hypoglycemia" [RGD:Rat Genome Database submission] |
Show
Allelic Composition: Trip13Gt(CH0621)Wtsi/Trip13Gt(CH0621)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0003383 | abnormal gluconeogenesis | "anomaly in the formation of glucose from noncarbohydrates, such as proteins or fat" [J:93896] |
Show
Allelic Composition: Trip13Gt(CH0621)Wtsi/Trip13Gt(CH0621)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0003402 | decreased liver weight | "reduced average weight of the bile-secreting exocrine gland" [csmith:Cynthia L. Smith , Mouse Genome Informatics Curator] |
Show
Allelic Composition: Trip13Gt(CH0621)Wtsi/Trip13Gt(CH0621)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0005217 | abnormal pancreatic beta cell morphology | "malformation of the cells of the pancreas that secrete insulin" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd,Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd Genetic Background: involves: 129S6/SvEvTac * 129X1/SvJ
|
MP:0005668 | decreased circulating leptin level | "less than the normal blood concentration of the peptide hormone secreted by white adipocytes and believed to regulate food intake and energy balance" [MeSH:National Library of Medicine - Medical Subject Headings, 2003, J:34751] |
Show
Allelic Composition: Trip13Gt(CH0621)Wtsi/Trip13Gt(CH0621)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0006059 | decreased susceptibility to ischemic brain injury | "decreased lesion size following loss of circulation in a region of the brain; may be induced or spontaneous" [smb:Susan M Bello, Mouse Genome Informatics Curator] |
Show
Allelic Composition: Cenpbtm1Khac/Cenpbtm1Khac Genetic Background: B6.129-Cenpbtm1Khac
|
MP:0008236 | decreased susceptibility to neuronal excitotoxicity | "less than normal amount of neuronal cell death following exposure to a neurotoxic compound, such as kaniate-induced neuronal cell death mediated via a glutamate excitotoxic process" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Mapk7tm1Wnt/Mapk7tm1Wnt Genetic Background: involves: C57BL/6
|
MP:0009356 | decreased liver triglyceride level | "lower than normal concentration of triacylglycerols in the liver" [MGI:smb "Susan M. Bello, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Trip13Gt(CH0621)Wtsi/Trip13Gt(CH0621)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0010379 | decreased respiratory quotient | "reduction in the ratio of the volume of carbon dioxide released to oxygen consumed by a body tissue or an organism compared to controls" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Trip13Gt(CH0621)Wtsi/Trip13Gt(CH0621)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0011085 | complete postnatal lethality | "premature death anytime between the neonatal period and weaning age of all organisms of a given genotype in a population (Mus: P1 to approximately 3 weeks of age)" [MGI:csmith] |
Show
Allelic Composition: Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd,Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd Genetic Background: involves: 129S6/SvEvTac * 129X1/SvJ
|
MP:0011094 | complete embryonic lethality before implantation | "death of all organisms of a given genotype in a population between fertilization and implantation (Mus: E0 to less than E4.5)" [MGI:csmith] |
Show
Allelic Composition: Mapk7tm1Wnt/Mapk7tm1Wnt Genetic Background: involves: C57BL/6
|
MP:0011940 | decreased food intake | "reduction in the total number of calories/food amount taken in over time when compared to the normal state" [MGI:csmith] |
Show
Allelic Composition: Trip13Gt(CH0621)Wtsi/Trip13Gt(CH0621)Wtsi Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|